With this goal in mind, this study was designed to examine the contribution of glucocorticoid signaling to the expression of CLU and LEDGF/p75, two stress oncoproteins previously established as key contributors to therapy resistance in various cancer types18,20–22,26–29. The gene discussed is PSIP1; the disease is cancer.